Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Bradley Warady to Histocompatibility Testing

This is a "connection" page, showing publications Bradley Warady has written about Histocompatibility Testing.

 
Connection Strength
  
 
 
1.402
  
  1. Bryan CF, Chadha V, Warady BA. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm. Pediatr Transplant. 2016 Nov; 20(7):926-930.
    View in: PubMed
    Score: 0.580
  2. Bryan CF, Harrell K, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation. Transplant Proc. 1993 Dec; 25(6):3060-3.
    View in: PubMed
    Score: 0.121
  3. Bryan CF, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient. Transplant Proc. 1993 Dec; 25(6):3273-4.
    View in: PubMed
    Score: 0.121
  4. Bryan CF, Aeder MI, Helling TS, Hughes J, Luger AM, Nelson PW, Pierce GE, Shield CF, Warady B. Influence of HLA and race on long-term cadaveric renal transplantation. Transplant Proc. 1992 Dec; 24(6):2451-3.
    View in: PubMed
    Score: 0.113
  5. Bryan CF, Luger AM, Smith JL, Warady BA, Wakefield M, Schadde E, Murillo D, Nelson PW. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant. 2010 Jan-Feb; 24(1):56-61.
    View in: PubMed
    Score: 0.092
  6. Bryan CF, Wakefield M, Reese JC, Shield CF, Warady BA, Winklhofer FT, Murillo D. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transplant. 2007 Jan-Feb; 21(1):72-9.
    View in: PubMed
    Score: 0.075
  7. Bryan CF, Cherikh WS, Cheng Y, Aeder MI, Muruve NA, Nelson PW, Shield CF, Warady BA, Winklhofer FT. ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney. Clin Transplant. 2004; 18 Suppl 12:55-60.
    View in: PubMed
    Score: 0.061
  8. Bryan CF, Shield CF, Pierce GE, Warady BA, Aeder MI, Martinez J, Luger AM, Nelson PW, Ross G, Muruve N, Mitchell SI. Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens. Clin Transplant. 2000 Feb; 14(1):79-84.
    View in: PubMed
    Score: 0.046
  9. Bryan CF, Shield CF, Warady BA, Aeder MI, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Muruve N, Thien ER. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):225-7.
    View in: PubMed
    Score: 0.043
  10. Bryan CF, Baier KA, Nelson PW, Luger AM, Martinez J, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS, Muruve N. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation. 1998 Dec 27; 66(12):1827-32.
    View in: PubMed
    Score: 0.043
  11. Luger AM, Bryan CF, O'Brien BJ, Pierce GE, Shield CF, Warady BA, Aeder MI, Landreneau MD, Nelson PW, Ross G. Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization? Transplant Proc. 1996 Feb; 28(1):157-9.
    View in: PubMed
    Score: 0.035
  12. Bryan CF, Nelson PW, Shield CF, Ross G, Warady B, Murillo D, Winklhofer FT. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. Clin Transpl. 2004; 127-33.
    View in: PubMed
    Score: 0.015
  13. Bryan CF, Harrell KM, Mitchell SI, Warady BA, Aeder MI, Luger AM, Murillo D, Muruve NA, Nelson PW, Shield CF. HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors. Am J Transplant. 2003 Apr; 3(4):459-64.
    View in: PubMed
    Score: 0.014
  14. Muruve NA, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Bryan CF. Effect of donor brain-death duration on graft outcome. Transplant Proc. 2001 Sep; 33(6):2980-1.
    View in: PubMed
    Score: 0.013
  15. Bryan CF, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Harrell KM, Helling TS, Luger AM. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype. Clin Transplant. 2001; 15 Suppl 6:28-35.
    View in: PubMed
    Score: 0.012
  16. Bryan CF, Mitchell SI, Lin HM, Nelson PW, Shield CF, Luger AM, Pierce GE, Ross G, Warady BA, Aeder MI, Helling TS, Landreneau MD, Harrell KM. Influence of the Rh (D) blood group system on graft survival in renal transplantation. Transplantation. 1998 Feb 27; 65(4):588-92.
    View in: PubMed
    Score: 0.010
  17. Bryan CF, Shield CF, Warady BA, Aeder MI, Landreneau MD, Luger AM, Nelson PW, Pierce GE, Ross G. Allocation of kidneys to Afro-American patients is proportional to wait-list composition. Transplant Proc. 1996 Feb; 28(1):219-20.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.